K. Beaumont et al., REGULATION OF MUSCLE GLYCOGEN-METABOLISM BY CGRP AND AMYLIN - CGRP RECEPTORS NOT INVOLVED, British Journal of Pharmacology, 115(5), 1995, pp. 713-715
The aim of the present study was to determine whether amylin and calci
tonin gene-related peptide (CGRP) act through shared or distinct recep
tors to inhibit insulin-stimulated incorporation of [C-14]-glucose int
o glycogen. Rat amylin was 3 fold more potent than either rat alpha CG
RP or rat beta CGRP at reducing glycogen synthesis from [C-14]-glucose
in insulin-treated rat soleus muscle. This action was blocked by pept
ide antagonists, with the rank order of potency being AC187>salmon cal
citonin(8-32) (sCT(8-32)) > h-alpha CGRP(8-37) for antagonism of eithe
r amylin or CGRP. The antagonist potency order correlated with affinit
y for amylin receptors measured in rat nucleus accumbens but not CGRP
receptors measured in rat L6 muscle cells. Inhibition of glucose incor
poration into glycogen by amylin and CGRP appears to be mediated by sh
ared receptors that have the pharmacological characteristics of amylin
receptors, and are distinct from previously described CGRP receptors.